Pitavastatin: evidence for its place in treatment of hypercholesterolemia.
about
Molecular mechanisms underlying the effects of statins in the central nervous system.Benefit-risk assessment of pitavastatin for the treatment of hypercholesterolemia in older patients.Statins of high versus low cholesterol-lowering efficacy and the development of severe renal failure.Rhabdomyolysis and AKI with Atorvastatin and Sitagliptin Use in the Setting of Low 25-Hydroxyvitamin D Levels.
P2860
Pitavastatin: evidence for its place in treatment of hypercholesterolemia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pitavastatin: evidence for its place in treatment of hypercholesterolemia.
@ast
Pitavastatin: evidence for its place in treatment of hypercholesterolemia.
@en
Pitavastatin: evidence for its place in treatment of hypercholesterolemia.
@nl
type
label
Pitavastatin: evidence for its place in treatment of hypercholesterolemia.
@ast
Pitavastatin: evidence for its place in treatment of hypercholesterolemia.
@en
Pitavastatin: evidence for its place in treatment of hypercholesterolemia.
@nl
prefLabel
Pitavastatin: evidence for its place in treatment of hypercholesterolemia.
@ast
Pitavastatin: evidence for its place in treatment of hypercholesterolemia.
@en
Pitavastatin: evidence for its place in treatment of hypercholesterolemia.
@nl
P2860
P356
P1433
P1476
Pitavastatin: evidence for its place in treatment of hypercholesterolemia.
@en
P2093
Peter Alagona
P2860
P304
P356
10.2147/CE.S8008
P407
P577
2010-10-22T00:00:00Z